PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93023P00594YEARLY license (maintenance — Dna Twopointo Inc

Dna Twopointo Inc holds $225K across 1 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the May 13, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid

Awarding office

Dna Twopointo Inc

Recipient

May 13, 2027

PoP end

$225K

Obligated

$375K

Potential

325414

NAICS

6505

PSC

NONE

Set-aside

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Dna Twopointo Inc — $90

Contract facts

NONE

Contract number75N93023P00594

AgencyNational Institutes Of Health Niaid

Awarding officeNational Institutes Of Health Niaid

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentDna Twopointo Inc

CAGE3ENW7

UEIG9S3SC8T5DM1

NAICS325414

No full NAICS 325414 intel page yet. Browse NAICS intelligence

PSC6505

Place of performanceNEWARK CA

Pricing typeFirm Fixed Price

Extent competedNot Competed Under SAP

Related solicitationNOI-NIAID-23-2168820

PoP startMay 14, 2023

PoP end (current)May 13, 2027

PoP end (w/ options)May 13, 2028

Obligated$225K

Current value$300K

Potential value$375K

YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY is a federal NONE award for National Institutes Of Health Niaid held by Dna Twopointo Inc. Estimated value $375K ($225K obligated). Current period of performance ends May 13, 2027 (potential May 13, 2028). Last award drew 1 bidder. Place of performance: NEWARK CA. Related solicitation NOI-NIAID-23-2168820.

YEARLY LICENSE (MAINTENANCE FEE AND IND FILING FEE) TO USE A MONOCLONAL ANTIBODY PRODUCED VIA ATUM PROPRIETARY CELL LINE TECHNOLOGY

Recompete timing

Public

● Expiring in 265 days

Current PoP ends May 13, 2027 (265 days remaining). Agencies typically plan 12–18 months ahead — at 8.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Dna Twopointo Inc — $225K obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$225K · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N93023P00594?

75N93023P00594 (YEARLY license (maintenance) is a National Institutes Of Health Niaid award with a potential value of $375K, currently held by Dna Twopointo Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93023P00594?

National Institutes Of Health Niaid awarded 75N93023P00594 to Dna Twopointo Inc (potential $375K).

Who is the incumbent on 75N93023P00594?

Dna Twopointo Inc is the incumbent with $225K across 1 related awards in SCOUT’s public footprint. The current period of performance ends May 13, 2027.

When does Dna Twopointo Inc’s 75N93023P00594 come up for recompete?

SCOUT tracks a period-of-performance end of May 13, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jul 20, 2026